SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tunica Albuginea who wrote (4730)1/17/1998 11:16:00 PM
From: blankmind   of 23519
 
-- Vivus's cash position is awfully robust. Right after the confer call in december, several bears were saying how CEO Leland was being evasive. And the cash position would be cut due to plant expansion and everything else. I'm glad to report that none of these gloom & doom scenarios came to be.

-- In fact, this is what I found:

1. Cash (& equiv) position on 9/30/97 - $97 mill

2. Cash (& equiv) position on 12/31/97 - $92 mill

3. Although cash shrunk by $5 mill...

a. liabilities shrank by $1.5 mill

b. Prop, plant & equip increased by $10 mill

c. some type of share buyback - I believe 200k shs @ ??? - about $2 or $3 mill

d. Inventories increased by $2.8 mill

-- My point is that VVUS continues to be a cash cow.

Out.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext